>>> US Gapping down

Gapping down

In reaction to disappointing earnings/guidance: ININ -17.6%, AEIS -12.9%, MED -10.4%, FN -10.2%, SGY -5.3% (also downgraded to Underperform from Neutral at Credit Suisse), MR -4.4%, (announces that Mr. Jie Liu has resigned from his Chief Operating Officer position for personal reasons, effective immediately), ECOM -4.4%, HCLP -4.4%, KWK -4.4% (ticking lower), ZBRA -3%,AIG -2.9%, LF -2.9%, HFC -2.9%, CYNO -2.8%, BCS -2.8%, YY -2.7%, SMG -2.5%, NUS -2.4%, MTSC -2.3%, (light volume), VECO -1.9%, PRI -1.8%, (light volume), BNFT -1.8%, SZYM -1.5%, MOS -1%, AZN -0.5% (also receives FDA approval for EPANOVA for the treatment of adults with severe hypertriglyceridemia).

Other news: ATHN -11.2% ( Greenlight's David Einhorn making cautious comments on ATHN at Ira Sohn, believes it could fall 80%), TWTR -2.7% (TWTR lock up expiration; also reports out discussing video ad launch), LGF -1.6% (Divergent tops $250 mln at the worldwide box office ), MMP -1.5% (announces it is proceeding with its pipeline project to deliver refined petroleum products to Little Rock, Arkansas, supported by commitments from its recent open season), SHPG -1.3% (still checking), DB -0.9% (Moody's Reviews Deutsche Bank (A2 for Deposits) for Possible Downgrade), AMT -0.8% ( announces proposed public offering of mandatory convertible preferred stock ), -0.5% (still checking), AZN -0.5% (receives FDA approval for EPANOVA for the treatment of adults with severe hypertriglyceridemia), BBY -0.4% (disclosed yesterday Chief Commercial Officer Jude C. Buckley resigned to pursue other interests, effective immediately).